Open access
Sep 2026
Real-World Testing Landscape and Costs of Companion Diagnostics and Comprehensive Genomic Profiling Across Nine Solid Tumors in Japan: A 10-Year Analysis.
Early implementation of CGP testing could reduce redundant testing and associated delays in treatment, thereby contributing to lower overall healthcare costs and more efficient treatment selection amid rapid advances in targeted therapies.
K. Sunami, Sona-Sanae Aoyagi, Masashi Mikami et al.
· Oncology and Therapy · 0 citations